1JVQ - JenaLib

Asym./Biol. Unit - manually (Jmol Viewer)

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN, A P14-P8 REACTIVE LOOP PEPTIDE, AND AN EXOGENOUS TETRAPEPTIDE

Authors :   A. Zhou, J. A. Huntington, D. A. Lomas, R. W. Carrell, P. E. Stein

Date :   31 Aug 01 (Deposition) - 03 Jun 03 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.60

Chains :   Asym./Biol. Unit : C,D,I,L

Keywords :   Loop-Sheet Polymer, Beta-Barrel, Blood Clotting, Hydrolase-Hydrolase Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   A. Zhou, P. E. Stein, J. A. Huntington, P. Sivasothy, D. A. Lomas, R. W. Carrell
How Small Peptides Block And Reverse Serpin Polymerisation
J. Mol. Biol. V. 342 931 2004
PubMed-ID: 15342247 | Reference-DOI: 10.1016/J.JMB.2004.07.078

Molecule 1 - ANTITHROMBIN-III
	Chains	:	L, I
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Other Details	:	PLASMA
	Synonym	:	ANTITHROMBIN, SERINE (OR CYSTEINE) PROTEINASE INHIBITOR, CLADE C (ANTITHROMBIN), MEMBER 1
	Tissue	:	BLOOD

Molecule 2 - P14-P8 REACTIVE LOOP PEPTIDE
	Chains	:	C
	Engineered	:	YES
	Fragment	:	HUMAN ANTITHROMBIN P14-P8 PEPTIDE
	Other Details	:	THIS SEQUENCE OCCURS NATURALLY IN HUMAN ANTITHROMBIN
	Synthetic	:	YES

Molecule 3 - EXOGENOUS CHOLECYSTOKININ TETRAPEPTIDE
	Chains	:	D
	Engineered	:	YES
	Fragment	:	CHOLECYSTOKININ PEPTIDE
	Other Details	:	THIS SEQUENCE OCCURS NATURALLY IN CHOLECYSTOKININ
	Synthetic	:	YES

		1	2	3	4
Asymmetric/Biological Unit	:	C	D	I	L

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (4, 11)

No.	Name	Count	Type	Full Name
1	ACE	1	Mod. Amino Acid	ACETYL GROUP
2	NAG	2	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
3	NDG	7	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
4	NH2	1	Mod. Amino Acid	AMINO GROUP

Asymmetric Unit (11, 11)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	CYS L:95 , ASN L:96	BINDING SITE FOR RESIDUE NDG L 801
02	AC2	SOFTWARE	ASN L:18 , PRO L:19 , MET L:20 , ASN L:155 , THR L:157 , ALA L:356 , NDG L:842	BINDING SITE FOR RESIDUE NDG L 841
03	AC3	SOFTWARE	ASN L:18 , PRO L:19 , NDG L:841	BINDING SITE FOR RESIDUE NDG L 842
04	AC4	SOFTWARE	ASP I:337 , LYS L:188 , ASN L:192	BINDING SITE FOR RESIDUE NDG L 861
05	AC5	SOFTWARE	ASN I:96	BINDING SITE FOR RESIDUE NDG I 801
06	AC6	SOFTWARE	ASN I:18 , MET I:20 , ASN I:155 , ALA I:356 , GLU I:357 , NDG I:842	BINDING SITE FOR RESIDUE NAG I 841
07	AC7	SOFTWARE	ASN I:18 , PRO I:19 , NAG I:841	BINDING SITE FOR RESIDUE NDG I 842
08	AC8	SOFTWARE	ASN I:192 , NDG I:862	BINDING SITE FOR RESIDUE NAG I 861
09	AC9	SOFTWARE	NAG I:861	BINDING SITE FOR RESIDUE NDG I 862
10	BC1	SOFTWARE	TRP D:9 , MET D:10 , SER I:79 , SER I:82 , ILE I:83 , VAL I:190 , ARG I:197 , ILE I:198 , VAL I:216 , ASN I:217 , THR I:218 , ILE I:219 , TYR I:220 , PHE I:221 , LYS I:222 , GLY I:223 , TRP I:225 , PHE I:274 , MET I:281 , PHE I:368 , HIS I:369 , LYS I:370 , ALA I:371 , PHE I:372 , LEU I:373 , GLU I:374 , VAL I:375 , ASN I:376 , PHE I:422	BINDING SITE FOR CHAIN C OF P14-P8 REACTIVE LOOP PEPTIDE
11	BC2	SOFTWARE	THR C:8 , PHE I:87 , THR I:90 , VAL I:201 , ILE I:202 , ALA I:206 , THR I:211 , VAL I:212 , LEU I:213 , VAL I:214 , LEU I:215 , LEU I:362 , TYR I:363 , SER I:365 , ASP I:366 , ALA I:367 , PHE I:368	BINDING SITE FOR CHAIN D OF EXOGENOUS CHOLECYSTOKININ TETRAPEPTIDE

Asymmetric/Biological Unit

No.	Residues
1	I:8	-	I:128
2	I:21	-	I:95
3	I:247	-	I:430
4	L:8	-	L:128
5	L:21	-	L:95
6	L:247	-	L:430

(no "Cis Peptide Bond" information available for 1JVQ)

Asymmetric/Biological Unit (85, 168)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	I/L	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I/L	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I	R	24	C
05	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I/L	R	47	C
06	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I/L	R	47	H
07	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I/L	R	47	S
08	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I/L	R	57	C
09	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	58	L
10	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	63	C
11	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	63	S
12	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	66	P
13	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	80	T
14	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	89	K
15	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I/L	G	93	D
16	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I/L	C	95	R
17	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I/L	L	99	F
18	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	99	V
19	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	Q	101	K
20	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I/L	K	114	E
21	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I/L	T	115	A
22	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I/L	S	116	P
23	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I/L	Q	118	P
24	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I/L	H	120	Y
25	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	126	P
26	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	128	Y
27	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I/L	R	129	Q
28	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I/L	N	135	T
29	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	138	P
30	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	146	H
31	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	147	L
32	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I/L	Y	158	C
33	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	166	C
34	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	166	H
35	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	182	F
36	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I/L	S	182	Y
37	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	186	N
38	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I/L	N	187	D
39	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	N	187	K
40	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I/L	S	191	P
41	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I/L	T	211	I
42	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I/L	V	216	G
43	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	219	T
44	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	W	225	R
45	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	229	L
46	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I/L	E	237	K
47	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	251	I
48	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	251	V
49	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	261	P
50	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	270	P
51	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	284	N
52	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	291	P
53	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	E	302	K
54	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I/L	S	349	P
55	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I/L	R	359	Q
56	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	365	P
57	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	D	366	H
58	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	H	369	R
59	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	380	R
60	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	L	A	382	T
61	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	I/L	A	384	P
62	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	I/L	A	384	S
63	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I/L	A	387	V
64	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I/L	G	392	D
65	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I/L	R	393	C
66	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I/L	R	393	H
67	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I/L	R	393	P
68	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I/L	S	394	L
69	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	402	C
70	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	402	L
71	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	402	S
72	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I/L	A	404	T
73	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	N	405	K
74	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	406	G
75	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	406	M
76	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	407	A
77	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I/L	P	407	L
78	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	407	T
79	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	409	P
80	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	421	T
81	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	G	424	R
82	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	425	T
83	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I/L	A	427	D
84	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I/L	P	429	L
85	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (1, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SERPIN	PS00284	Serpins signature.	ANT3_HUMAN	434-444	2	I:402-412 L:402-412

Asymmetric/Biological Unit (6, 12)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000367698	1a	ENSE00001944151	chr1:173886516-173886357	160	ANT3_HUMAN	1-14	14	0	-	-
1.3a	ENST00000367698	3a	ENSE00000814673	chr1:173884057-173883691	367	ANT3_HUMAN	14-136	123	2	I:5-104 (gaps) L:5-104 (gaps)	100 100
1.4c	ENST00000367698	4c	ENSE00000789910	chr1:173881152-173880937	216	ANT3_HUMAN	137-208	72	2	I:105-176 L:105-176	72 72
1.5a	ENST00000367698	5a	ENSE00000789909	chr1:173880029-173879892	138	ANT3_HUMAN	209-254	46	2	I:177-222 L:177-222	46 46
1.6b	ENST00000367698	6b	ENSE00000789908	chr1:173879080-173878690	391	ANT3_HUMAN	255-385	131	2	I:223-353 L:223-353	131 131
1.7a	ENST00000367698	7a	ENSE00001383315	chr1:173876652-173876588	65	ANT3_HUMAN	385-406	22	2	I:353-374 L:353-374	22 22
1.8a	ENST00000367698	8a	ENSE00001876994	chr1:173873203-173872947	257	ANT3_HUMAN	407-464	58	2	I:375-431 (gaps) L:375-431	57 57

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain C from PDB  Type:PROTEIN  Length:8
                                        
               SCOP domains -------- SCOP domains
               CATH domains -------- CATH domains
               Pfam domains -------- Pfam domains
         Sec.struct. author .eee.... Sec.struct. author
                 SAPs(SNPs) -------- SAPs(SNPs)
                    PROSITE -------- PROSITE
                 Transcript -------- Transcript
                 1jvq C   1 xSEAAAST   8
                            |       
                            1-ACE

Chain D from PDB  Type:PROTEIN  Length:5
                                     
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author ..... Sec.struct. author
                 SAPs(SNPs) ----- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                 1jvq D   9 WMDFx  13
                                |
                               13-NH2

Chain I from PDB  Type:PROTEIN  Length:410
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:427
                                    46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       
           ANT3_HUMAN    37 VDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 463
               SCOP domains d1jvqi_ I: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                     SCOP domains
               CATH domains -------1jvqI02 I:12-224              ,I:321-377 Antithrombin, subunit I, domain 2                                                                                                                                           1jvqI01 I:225-320,I:380-429 Alpha-1-antitrypsin, domain 1                                       1jvqI02 I:12-224,I:321-377                               --1   jvqI01 I:225-320,I:380-429                    -- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......hhhhh............--------------...hhhhhhhhhhhhhhhhhhhhhhhhh......eeehhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhh.......eeeeeeeeeee.....hhhhhhhhhhhhh.eeeee....hhhhhhhhhhhhhhhhh..................eeeeeeeeeee......hhhhheeeeee.....eeeeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhhhhhhhhhhhhhhh.eeeeeeeeee.eeeeeeeehhhhhhhh..hhhhh....................eeeeeeeeee.....---..eeeee.........eeee....eeeeeee....eeeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) --N------------TF--C----------------------C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R---P--V----DCL-------C-TKGA-P-----------T--RT-D-LF- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------ SAPs(SNPs) (3)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     ------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: I:5-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                         Exon 1.4c  PDB: I:105-176 UniProt: 137-208                              Exon 1.5a  PDB: I:177-222 UniProt: 209-254    Exon 1.6b  PDB: I:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: I:375-431 (gaps) UniProt: 407-464         Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             --------------------------------------------------------- Transcript 1 (2)
                 1jvq I   5 VDICTAKPRDIPMNPMCIYRSPE--------------EATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGS---ASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 431
                                    14        24  |      -       |44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374     | 384       394       404       414       424       
                                                 27             42                                                                                                                                                                                                                                                                                                                                               380 384

Chain L from PDB  Type:PROTEIN  Length:406
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:427
                                    46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       
           ANT3_HUMAN    37 VDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 463
               SCOP domains d1jvql_ L: Antithro                     mbin                                                                                                                                                                                                                                                                                                                                                                                                SCOP domains
               CATH domains -------1jvqL02 L:12                     -224,L:321-377 Antithrombin, subunit I, domain 2                                                                                                                                    1jvqL01 L:225-320,L:383-430 Alpha-1-antitrypsin, domain 1                                       1jvqL02 L:12-224,L:321-377                               -----1jvqL01 L:225-320,L:383-430                     - CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...................---------------------hhhhhhhhhhhhhhhhhhhhhhhh.......eeehhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhh......eeeeeeeeeee...eehhhhhhhhhhhh..eeeeehhhhhhhhhhhhhhhhhhhhh........hhhhh.....eeeeeeeeeeee..........ee..ee.....ee..eeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhh..hhhhhhhhhhhheeeeeeeeeeeeeeeeeeehhhhhhhh..hhhhh.........eee......eeeeeeeeeeee...eeeeeeeeeeee.................eeeeeee....eeeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) --N------------TF-------------------------C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------ SAPs(SNPs) (3)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     ------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: L:5-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                         Exon 1.4c  PDB: L:105-176 UniProt: 137-208                              Exon 1.5a  PDB: L:177-222 UniProt: 209-254    Exon 1.6b  PDB: L:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: L:375-431 UniProt: 407-464 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             --------------------------------------------------------- Transcript 1 (2)
                 1jvq L   5 VDICTAKPRDIPMNPMCIY---------------------NRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 431
                                    14        |-         -         -|       54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       
                                             23                    45

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Multi-domain proteins (alpha and beta) (2421)

Fold: Serpins (120)

Superfamily: Serpins (120)

Family: Serpins (100)

Protein domain: Antithrombin (28)

Human (Homo sapiens) [TaxId: 9606] (27)

1a	d1jvqi_	I:
1b	d1jvql_	L:

Asymmetric/Biological Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 2-Layer Sandwich (8480)

Topology: Antithrombin; Chain I, domain 2 (100)

Homologous Superfamily: Antithrombin, subunit I, domain 2 (100)

Human (Homo sapiens) (80)

1a	1jvqL02	L:12-224,L:321-377
1b	1jvqI02	I:12-224,I:321-377

Class: Mainly Beta (13760)

Architecture: Roll (1513)

Topology: Alpha-1-antitrypsin; domain 1 (101)

Homologous Superfamily: Alpha-1-antitrypsin, domain 1 (101)

Human (Homo sapiens) (81)

2a	1jvqI01	I:225-320,I:380-429
2b	1jvqL01	L:225-320,L:383-430

(no "Pfam Domain" information available for 1JVQ)

Asymmetric/Biological Unit(hide GO term definitions)

Chain I,L (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		ACE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NDG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NH2	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 1jvq)

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1jvq
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ANT3_HUMAN \| P01008
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	613118
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ANT3_HUMAN \| P01008
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1br8	2.9A STRUCTURE OF BINARY COMPLEXED ANTITHROMBIN. THIS IS DIMERIC ANTITHROMBIN COMPLEXED WITH A 12 RESIDUE PEPTIDE CORRESPONDING TO P14-P3 OF THE REACTIVE CENTRE LOOP

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (4, 11)

Sites (11, 11)

SS Bonds (6, 6)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (85, 168)

PROSITE Motifs (1, 2)

Exons (6, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (17, 17)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File